Tuesday, June 19, 2018

Neuropsychopharmacology - Table of Contents alert Volume 43 Issue 8

If you are unable to see the message below, click here to view.

Volume 43, Issue 8

In this issue
Research Highlight
Research Highlight
Review Article
Also new
Have you visited the Neuropsychopharmacology Archival Perspectives page? 

Highlighting the most cited articles from previous NPP issues. Recent additions include:

- Abnormal fear conditioning and amygdala processing in an animal model of autism
- Neural mechanisms of extinction learning and retrieval
- Neurobiological similarities in depression and drug dependence

Click here to access over 50 NPP articles from the past 5 years >>> 

Research Highlight

Clarifying punishment

Kate M. Wassum

Neuropsychopharmacology 2018 43 :1633 - 1634; April 13, 2018; 10.1038/s41386-018-0062-4


Abstract | Full Text


What a relief! A role for dopamine in positive (but not negative) valence

Melissa J Sharpe

Neuropsychopharmacology 2018 43 :1 - 2; February 27, 2018; 10.1038/s41386-018-0036-6


Abstract | Full Text

Research Highlight

Opportunities and needs in digital phenotyping

Lisa A. Marsch

Neuropsychopharmacology 2018 43 :1637 - 1638; April 03, 2018; 10.1038/s41386-018-0051-7


Abstract | Full Text

Review Article

Behavioral and neurobiological mechanisms of punishment: implications for psychiatric disorders

Philip Jean-Richard-Dit-Bressel, Simon Killcross & Gavan P. McNally

Neuropsychopharmacology 2018 43 :1639 - 1650; March 27, 2018; 10.1038/s41386-018-0047-3


Abstract | Full Text


Role of the mesolimbic dopamine system in relief learning

Dana Mayer, Evelyn Kahl, Taygun C. Uzuneser & Markus Fendt

Neuropsychopharmacology 2018 43 :1651 - 1659; February 05, 2018; 10.1038/s41386-018-0020-1


Abstract | Full Text

Relapse prediction in schizophrenia through digital phenotyping: a pilot study

Ian Barnett, John Torous, Patrick Staples, Luis Sandoval, Matcheri Keshavan et al.

Neuropsychopharmacology 2018 43 :1660 - 1666; February 22, 2018; 10.1038/s41386-018-0030-z


Abstract | Full Text

Cell-subtype-specific changes in adenosine pathways in schizophrenia

Sinead Marie O'Donovan, Courtney Sullivan, Rachael Koene, Emily Devine, Kathryn Hasselfeld et al.

Neuropsychopharmacology 2018 43 :1667 - 1674; February 26, 2018; 10.1038/s41386-018-0028-6


Abstract | Full Text

Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia

Joshua Chiappelli, Francesca M. Notarangelo, Ana Pocivavsek, Marian A. R. Thomas, Laura M. Rowland et al.

Neuropsychopharmacology 2018 43 :1675 - 1680; February 27, 2018; 10.1038/s41386-018-0038-4


Abstract | Full Text

Brain lactate and pH in schizophrenia and bipolar disorder: a systematic review of findings from magnetic resonance studies

Asli Ercan Dogan, Cagri Yuksel, Fei Du, Virginie-Anne Chouinard & Dost Öngür

Neuropsychopharmacology 2018 43 :1681 - 1690; March 14, 2018; 10.1038/s41386-018-0041-9


Abstract | Full Text

Abnormal reward prediction-error signalling in antipsychotic naive individuals with first-episode psychosis or clinical risk for psychosis

Anna O. Ermakova, Franziska Knolle, Azucena Justicia, Edward T. Bullmore, Peter B. Jones et al.

Neuropsychopharmacology 2018 43 :1691 - 1699; April 05, 2018; 10.1038/s41386-018-0056-2


Abstract | Full Text

Interaction between TSPO—a neuroimmune marker—and redox status in clinical high risk for psychosis: a PET–MRS study

Sina Hafizi, Tania Da Silva, Jeffrey H. Meyer, Michael Kiang, Sylvain Houle et al.

Neuropsychopharmacology 2018 43 :1700 - 1705; April 13, 2018; 10.1038/s41386-018-0061-5


Abstract | Full Text

Salivary kynurenic acid response to psychological stress: inverse relationship to cortical glutamate in schizophrenia

Joshua Chiappelli, Laura M. Rowland, Francesca M. Notarangelo, S. Andrea Wijtenburg, Marian A. R. Thomas et al.

Neuropsychopharmacology 2018 43 :1706 - 1711; April 18, 2018; 10.1038/s41386-018-0072-2


Abstract | Full Text

α7 Nicotinic receptor-modulating agents reverse the hyperdopaminergic tone in the MAM model of schizophrenia

Gilda A Neves & Anthony A Grace

Neuropsychopharmacology 2018 43 :1712 - 1720; April 19, 2018; 10.1038/s41386-018-0066-0


Abstract | Full Text

Mice with reduced DAT levels recreate seasonal-induced switching between states in bipolar disorder

Jared W. Young, Zackary A. Cope, Benedetto Romoli, Esther Schrurs, Aniek Joosen et al.

Neuropsychopharmacology 2018 43 :1721 - 1731; February 27, 2018; 10.1038/s41386-018-0031-y


Abstract | Full Text

Neural responses to cues paired with methamphetamine in healthy volunteers

Kathryne Van Hedger, Sarah K. Keedy, Leah M. Mayo, Markus Heilig & Harriet de Wit

Neuropsychopharmacology 2018 43 :1732 - 1737; January 30, 2018; 10.1038/s41386-017-0005-5


Abstract | Full Text

Neural activation to monetary reward is associated with amphetamine reward sensitivity

Natania A. Crane, Stephanie M. Gorka, Jessica Weafer, Scott A. Langenecker, Harriet de Wit et al.

Neuropsychopharmacology 2018 43 :1738 - 1744; March 14, 2018; 10.1038/s41386-018-0042-8


Abstract | Full Text

Cognitive deficit in methamphetamine users relative to childhood academic performance: link to cortical thickness

Andy C. Dean, Angelica M. Morales, Gerhard Hellemann & Edythe D. London

Neuropsychopharmacology 2018 43 :1745 - 1752; April 20, 2018; 10.1038/s41386-018-0065-1


Abstract | Full Text

Amphetamine maintenance differentially modulates effects of cocaine, methylenedioxypyrovalerone (MDPV), and methamphetamine on intracranial self-stimulation and nucleus accumbens dopamine in rats

Amy R. Johnson, Matthew L. Banks, Dana E. Selley & S. Stevens Negus

Neuropsychopharmacology 2018 43 :1753 - 1762; April 19, 2018; 10.1038/s41386-018-0071-3


Abstract | Full Text

M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition

Sean P. Moran, Jonathan W. Dickerson, Hyekyung P. Cho, Zixiu Xiang, James Maksymetz et al.

Neuropsychopharmacology 2018 43 :1763 - 1771; March 14, 2018; 10.1038/s41386-018-0033-9


Abstract | Full Text

A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures

Laura C. Politte, Lawrence Scahill, Janet Figueroa, James T. McCracken, Bryan King et al.

Neuropsychopharmacology 2018 43 :1772 - 1778; February 27, 2018; 10.1038/s41386-018-0039-3


Abstract | Full Text

Histone deacetylase inhibitor MS-275 restores social and synaptic function in a Shank3-deficient mouse model of autism

Kaijie Ma, Luye Qin, Emmanuel Matas, Lara J. Duffney, Aiyi Liu et al.

Neuropsychopharmacology 2018 43 :1779 - 1788; April 19, 2018; 10.1038/s41386-018-0073-1


Abstract | Full Text

Embryonic stem cell transplants as a therapeutic strategy in a rodent model of autism

Jennifer J. Donegan, Angela M. Boley & Daniel J. Lodge

Neuropsychopharmacology 2018 43 :1789 - 1798; February 07, 2018; 10.1038/s41386-018-0021-0


Abstract | Full Text

Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours.

Click here to sign up.
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Neuropsychopharmacology.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: